Bank of America reiterated their underperform rating on shares of Nu Skin Enterprises (NYSE:NUS) in a report published on Wednesday, Briefing.com Automated Import reports. Bank of America currently has a $52.00 price target on the stock, down from their previous price target of $57.00.

Other equities analysts also recently issued research reports about the stock. Pivotal Research reissued a buy rating and issued a $85.00 target price on shares of Nu Skin Enterprises in a research note on Wednesday, March 13th. Deutsche Bank raised shares of Nu Skin Enterprises from a hold rating to a buy rating and set a $60.00 target price on the stock in a research note on Wednesday, May 1st. Zacks Investment Research raised shares of Nu Skin Enterprises from a sell rating to a hold rating in a research note on Friday, May 3rd. ValuEngine raised shares of Nu Skin Enterprises from a sell rating to a hold rating in a research note on Wednesday, May 1st. Finally, Stifel Nicolaus downgraded shares of Nu Skin Enterprises from a hold rating to a sell rating and cut their target price for the company from $63.00 to $43.00 in a research note on Monday, March 25th. Three equities research analysts have rated the stock with a sell rating, one has given a hold rating and six have issued a buy rating to the company’s stock. The stock has a consensus rating of Hold and a consensus price target of $73.13.

Shares of NUS opened at $48.87 on Wednesday. The firm has a market capitalization of $2.71 billion, a price-to-earnings ratio of 13.88, a P/E/G ratio of 1.10 and a beta of 0.73. Nu Skin Enterprises has a fifty-two week low of $44.36 and a fifty-two week high of $88.68. The company has a current ratio of 1.86, a quick ratio of 1.10 and a debt-to-equity ratio of 0.44.

Nu Skin Enterprises (NYSE:NUS) last announced its quarterly earnings results on Tuesday, April 30th. The company reported $0.77 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.71 by $0.06. The company had revenue of $623.60 million for the quarter, compared to analyst estimates of $615.98 million. Nu Skin Enterprises had a net margin of 4.82% and a return on equity of 26.81%. Nu Skin Enterprises’s revenue for the quarter was up 1.2% on a year-over-year basis. During the same quarter last year, the business earned $0.79 EPS. Sell-side analysts forecast that Nu Skin Enterprises will post 3.92 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which was paid on Wednesday, June 12th. Stockholders of record on Friday, May 31st were paid a $0.37 dividend. This represents a $1.48 dividend on an annualized basis and a dividend yield of 3.03%. The ex-dividend date was Thursday, May 30th. Nu Skin Enterprises’s dividend payout ratio is presently 42.05%.

Hedge funds have recently modified their holdings of the company. Quadrant Capital Group LLC increased its stake in Nu Skin Enterprises by 823.3% during the 1st quarter. Quadrant Capital Group LLC now owns 554 shares of the company’s stock worth $26,000 after buying an additional 494 shares during the period. YorkBridge Wealth Partners LLC purchased a new stake in Nu Skin Enterprises during the 4th quarter worth $31,000. Meeder Asset Management Inc. purchased a new stake in Nu Skin Enterprises during the 1st quarter worth $65,000. Investors Research Corp purchased a new stake in Nu Skin Enterprises during the 1st quarter worth $73,000. Finally, Quantamental Technologies LLC purchased a new stake in Nu Skin Enterprises during the 1st quarter worth $86,000. 77.17% of the stock is currently owned by institutional investors and hedge funds.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic and personal care products.

Read More: Buyback For Investors Defined

Analyst Recommendations for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.